US Bancorp DE Boosts Holdings in Avantor, Inc. (NYSE:AVTR)

US Bancorp DE raised its position in shares of Avantor, Inc. (NYSE:AVTR) by 6.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,615 shares of the company’s stock after purchasing an additional 734 shares during the quarter. US Bancorp DE’s holdings in Avantor were worth $326,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Swedbank AB purchased a new position in Avantor during the first quarter valued at approximately $2,707,000. William Blair Investment Management LLC lifted its holdings in Avantor by 44.6% during the first quarter. William Blair Investment Management LLC now owns 1,047,732 shares of the company’s stock valued at $26,791,000 after purchasing an additional 322,985 shares in the last quarter. Sound Shore Management Inc. CT purchased a new position in Avantor during the second quarter valued at approximately $76,412,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Avantor by 18.5% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 353,687 shares of the company’s stock valued at $9,044,000 after purchasing an additional 55,129 shares in the last quarter. Finally, Seven Eight Capital LP purchased a new position in Avantor during the second quarter valued at approximately $642,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Trading Down 2.2 %

Shares of NYSE:AVTR opened at $21.80 on Wednesday. Avantor, Inc. has a 1 year low of $18.41 and a 1 year high of $28.00. The firm has a market capitalization of $14.84 billion, a price-to-earnings ratio of 48.48, a price-to-earnings-growth ratio of 2.73 and a beta of 1.35. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The business’s 50 day moving average price is $24.84 and its 200-day moving average price is $24.08.

Analyst Upgrades and Downgrades

AVTR has been the topic of several research analyst reports. Stifel Nicolaus boosted their target price on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Barclays reduced their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Morgan Stanley boosted their price target on shares of Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. TD Cowen boosted their price objective on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Finally, Wells Fargo & Company cut their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $27.57.

Insider Activity

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.50% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.